SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (544)8/16/2001 12:12:40 AM
From: IRWIN JAMES FRANKEL  Read Replies (1) of 656
 
Thanks Richard for the science lesson.

While reading today I read that the MOA for Remicade and Enbrel differs in an important way. As I understood, Remicade kills the cells that produce TNF while Enbrel attaches to and removes TNF without interfering with the cells that can continue to produce the TNF. That was suggested as the reason that Enbrel seems to be having fewer uncontrolled infections.

Is that close?

If it is, it suggests a good future for Enbrel.

Yes, I have bought some IMNX.

ij
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News